BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19160520)

  • 1. A-94964, a novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. I. Taxonomy, isolation and biological activity.
    Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2008 Sep; 61(9):537-44. PubMed ID: 19160520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-94964, novel inhibitor of bacterial translocase I, produced by Streptomyces sp. SANK 60404. II. Physico-chemical properties and structure elucidation.
    Fujita Y; Murakami R; Muramatsu Y; Miyakoshi S; Takatsu T
    J Antibiot (Tokyo); 2008 Sep; 61(9):545-9. PubMed ID: 19160521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.
    Muramatsu Y; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2004 Oct; 57(10):639-46. PubMed ID: 15638324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206.
    Murakami R; Fujita Y; Kizuka M; Kagawa T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2007 Nov; 60(11):690-5. PubMed ID: 18057698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A-90289 A and B, new inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 60405.
    Fujita Y; Kizuka M; Funabashi M; Ogawa Y; Ishikawa T; Nonaka K; Takatsu T
    J Antibiot (Tokyo); 2011 Jul; 64(7):495-501. PubMed ID: 21587261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.
    Muramatsu Y; Muramatsu A; Ohnuki T; Ishii MM; Kizuka M; Enokita R; Tsutsumi S; Arai M; Ogawa Y; Suzuki T; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):243-52. PubMed ID: 12760680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel isoquinoline alkaloid, DD-carboxypeptidase inhibitor, with antibacterial activity isolated from Streptomyces sp. 8812. Part I: Taxonomy, fermentation, isolation and biological activities.
    Solecka J; Rajnisz A; Laudy AE
    J Antibiot (Tokyo); 2009 Oct; 62(10):575-80. PubMed ID: 19713994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
    Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
    J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties.
    Iwatsuki M; Uchida R; Yoshijima H; Ui H; Shiomi K; Matsumoto A; Takahashi Y; Abe A; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Apr; 61(4):222-9. PubMed ID: 18503201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of a disaccharide isolated from Streptomyces sp. strain JJ45 against Xanthomonas sp.
    Kang YS; Lee Y; Cho SK; Lee KH; Kim BJ; Kim M; Lim Y; Cho M
    FEMS Microbiol Lett; 2009 May; 294(1):119-25. PubMed ID: 19493015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.
    Brandish PE; Kimura KI; Inukai M; Southgate R; Lonsdale JT; Bugg TD
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1640-4. PubMed ID: 8807054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics.
    Kimura KI
    J Antibiot (Tokyo); 2019 Dec; 72(12):877-889. PubMed ID: 31582803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis.
    Kimura K; Bugg TD
    Nat Prod Rep; 2003 Apr; 20(2):252-73. PubMed ID: 12735700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.
    Muramatsu Y; Ishii MM; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):253-8. PubMed ID: 12760681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.
    Muramatsu Y; Miyakoshi S; Ogawa Y; Ohnuki T; Ishii MM; Arai M; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):259-67. PubMed ID: 12760682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel antibiotic, sohbumycin. Taxonomy, fermentation, isolation and physico-chemical and biological characteristics.
    Umezawa I; Tronquet C; Funayama S; Okada K; Komiyama K
    J Antibiot (Tokyo); 1985 Aug; 38(8):967-71. PubMed ID: 3840156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.
    Ohnuki T; Muramatsu Y; Miyakoshi S; Takatsu T; Inukai M
    J Antibiot (Tokyo); 2003 Mar; 56(3):268-79. PubMed ID: 12760683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization, and structural elucidation of 4-methoxyacetanilide from marine actinobacteria Streptomyces sp. SCA29 and evaluation of its enzyme inhibitory, antibacterial, and cytotoxic potential.
    Siddharth S; Vittal RR
    Arch Microbiol; 2019 Aug; 201(6):737-746. PubMed ID: 30820617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.
    Hering J; Dunevall E; Ek M; Brändén G
    Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.